RAIDD Mediates TLR3 and IRF7 Driven Type i Interferon Production

Cellular Physiology and Biochemistry

Volumn 39, Issue 4, 2016, Pages 1271-1280

  Maney, Sathish Kumar ^a   Xu, Haifeng C ^a   Huang, Jun ^a   Pandyra, Aleksandra A ^b   Ehlting, Christian ^a   Aguilar Valenzuela, Renan ^a   Pozdeev, Vitaly I ^a   McIlwain, David R ^a   Zimmermann, Albert ^a   Bode, Johannes G ^a   Hengel, Hartmut ^a,c   Kirschning, Carsten J ^b   Kim, Ira R ^d   Hiscott, John ^e   Brenner, Dirk ^f,g   Häussinger, Dieter ^a   Ohashi, Pamela S ^d   Mak, Tak W ^d   Lang, Karl S ^b   Lang, Philipp A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e Pasteur Institute   (Italy)

^f LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Innate immunity; IRF7; RAIDD; TLR

Indexed keywords

CRADD PROTEIN; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 7; TOLL LIKE RECEPTOR 3; ALPHA INTERFERON; BETA INTERFERON; CRADD PROTEIN, HUMAN; I KAPPA B KINASE; IRF7 PROTEIN, HUMAN; LUCIFERASE; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT PROTEIN; TLR3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERFERON PRODUCTION; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ANIMAL; CASPASE ACTIVATION AND RECRUITMENT DOMAIN; CHEMISTRY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; MOUSE; PLASMID; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; CASPASE ACTIVATION AND RECRUITMENT DOMAIN; CRADD SIGNALING ADAPTOR PROTEIN; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC VECTORS; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; INTERFERON-BETA; LENTIVIRUS; LUCIFERASES; MICE; PLASMIDS; POLY I-C; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84986563750     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000447832     Document Type: Article

References (43)

1. McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A: Type I interferons in infectious disease. Nat Rev Immunol 2015; 15: 87-103.
2. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
3. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529.
4. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S, Teti G, Beninati C: Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 2009; 10: 587-594.
5. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738.
6. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S: Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5: 1061-1068.
7. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC: Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002; 416: 750-756.
8. Ramirez-Ortiz ZG, Prasad A, Griffith JW, Pendergraft WF, 3rd, Cowley GS, Root DE, Tai M, Luster AD, El Khoury J, Hacohen N, Means TK: The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity. Nat Immunol 2015; 16: 495-504.
9. Clark K, Takeuchi O, Akira S, Cohen P: The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. Proc Natl Acad Sci USA 2011; 108: 17093-17098.
10. Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H, Ohara O, Akira S, Kaisho T: IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 2006; 440: 949-953.
11. Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.
12. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S: Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301: 640-643.
13. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G: Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 2006; 439: 208-211.
14. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Hacker G, Mann M, Karin M: Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006; 439: 204-207.
15. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T: IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491-496.
16. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J: Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300: 1148-1151.
17. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB: Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008; 14: 1077-1087.
18. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000; 13: 539-548.
19. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772-777.
20. Lang PA, Cervantes-Barragan L, Verschoor A, Navarini AA, Recher M, Pellegrini M, Flatz L, Bergthaler A, Honda K, Ludewig B, Ohashi PS, Lang KS: Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 2009; 113: 1045-1052.
21. Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H: The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 2007; 25: 561-586.
22. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997; 57: 615-619.
23. Duan H, Dixit VM: RAIDD is a new 'death' adaptor molecule. Nature 1997; 385: 86-89.
24. Berube C, Boucher LM, Ma W, Wakeham A, Salmena L, Hakem R, Yeh WC, Mak TW, Benchimol S: Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc Natl Acad Sci USA 2005; 102: 14314-14320.
25. Tu S, McStay GP, Boucher LM, Mak T, Beere HM, Green DR: In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol 2006; 8: 72-77.
26. Imre G, Heering J, Takeda AN, Husmann M, Thiede B, zu Heringdorf DM, Green DR, van der Goot FG, Sinha B, Dotsch V, Rajalingam K: Caspase-2 is an initiator caspase responsible for pore-forming toxin-mediated apoptosis. EMBO J 2012; 31: 2615-2628.
27. Lin Q, Liu Y, Moore DJ, Elizer SK, Veach RA, Hawiger J, Ruley HE: Cutting edge: the "death" adaptor CRADD/ RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes. J Immunol 2012; 188: 2493-2497.
28. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, Lammens K, Fujita T, Conzelmann KK, Krug A, Hopfner KP: The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 2008; 29: 169-179.
29. van Pesch V, Michiels T: Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem 2003; 278: 46321-46328.
30. Kawai T, Akira S: Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
31. Lee MS, Kim B, Oh GT, Kim YJ: OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat Immunol 2013; 14: 346-355.
32. Siednienko J, Jackson R, Mellett M, Delagic N, Yang S, Wang B, Tang LS, Callanan JJ, Mahon BP, Moynagh PN: Pellino3 targets the IRF7 pathway and facilitates autoregulation of TLR3-and viral-induced expression of type I interferons. Nat Immunol 2012; 13: 1055-1062.
33. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101-105.
34. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6: 981-988.
35. Park HH, Wu H: Crystallization and preliminary X-ray crystallographic studies of the oligomeric death-domain complex between PIDD and RAIDD. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007; 63: 229-232.
36. Shearwin-Whyatt LM, Harvey NL, Kumar S: Subcellular localization and CARD-dependent oligomerization of the death adaptor RAIDD. Cell Death Differ 2000; 7: 155-165.
37. Peintner L, Dorstyn L, Kumar S, Aneichyk T, Villunger A, Manzl C: The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd. Cell Death Differ 2015; 22: 1803-1811.
38. Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F, Logette E, Tschopp J, Villunger A: Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol 2009; 185: 291-303.
39. Kawai T, Akira S: Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-137.
40. Duncan GS, Mittrucker HW, Kagi D, Matsuyama T, Mak TW: The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 1996; 184: 2043-2048.
41. Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, Lafaille FG, Trouillet C, Schmolke M, Albrecht RA, Israelsson E, Lim HK, Casadio M, Hermesh T, Lorenzo L, Leung LW, Pedergnana V, Boisson B, Okada S, Picard C, Ringuier B, Troussier F, Chaussabel D, Abel L, Pellier I, Notarangelo LD, Garcia-Sastre A, Basler CF, Geissmann F, Zhang SY, Snoeck HW, Casanova JL: Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 2015; 348: 448-453.
42. Ivashkiv LB, Donlin LT: Regulation of type I interferon responses. Nat Rev Immunol 2014; 14: 36-49.
43. You F, Wang P, Yang L, Yang G, Zhao YO, Qian F, Walker W, Sutton R, Montgomery R, Lin R, Iwasaki A, Fikrig E: ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol 2013; 14: 1237-1246.